Extract Technology

Executive Summary

Extract Technology is a UK-based leader in containment and aseptic systems, supplying isolators, gloveboxes, and mobile cleanrooms to pharmaceutical, biotech, and chemical industries. Founded in 1998 and now a strategic subsidiary of the global Dec Group, the company protects operators from potent compounds and products from contamination. With over 25 years of expertise, Extract Technology is well-positioned to benefit from the growing demand for high-containment solutions driven by the rise of highly potent active pharmaceutical ingredients (HPAPIs) and advanced therapy medicinal products (ATMPs). Its integration into Dec Group expands its global reach and solution portfolio, enabling cross-selling opportunities and access to larger projects. While the company is private with limited financial disclosure, its established reputation, regulatory compliance expertise, and alignment with industry trends suggest a stable growth trajectory. The expansion of HPAPI manufacturing and increasing regulatory focus on operator safety are key demand drivers. Extract Technology's ability to offer integrated containment solutions, from standalone isolators to complete aseptic filling lines, positions it as a valuable partner in the pharmaceutical supply chain. Overall, the company is poised for steady growth, supported by its parent group's resources and market trends.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation isolator with enhanced automation and monitoring70% success
• Q2 2026New regulatory guidelines for safe handling of potent compounds (EU GMP Annex 1 updates)80% success
• Q3 2026Expansion into Asian markets via Dec Group's distribution network60% success